世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

抗生物質耐性 - 世界市場シェア・ランキング、全体売上高・需要予測 2024-2030


Antibiotic Resistance - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

抗生物質は様々な細菌感染を防ぐために使用される薬であり、抗生物質耐性とは微生物が抗生物質の効果に耐えられないことである。薬剤耐性の一種である。これらの細菌はヒトや動物の体に感染する可能性があり、こ... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2024年3月1日 US$3,950
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

抗生物質は様々な細菌感染を防ぐために使用される薬であり、抗生物質耐性とは微生物が抗生物質の効果に耐えられないことである。薬剤耐性の一種である。これらの細菌はヒトや動物の体に感染する可能性があり、これらの細菌が引き起こす感染症は、非耐性菌が引き起こす感染症よりも治療が困難である。従って、抗生物質耐性は医療費の増加や死亡率の上昇につながります。
抗生物質耐性の世界市場は、2023年には100万米ドル規模と推定され、2024-2030年の予測期間中に年平均成長率(CAGR)%で2030年までに100万米ドルに再調整されると予測されています。

世界の医薬品市場は2022年に1,475億米ドルとなり、今後6年間のCAGRは5%で成長する。医薬品市場には、化学医薬品と生物学的製剤が含まれる。生物製剤は2022年に3810億米ドルになると予想されている。これに対し、化学医薬品市場は2018年の1,050億米ドルから2022年には1,090億米ドルに増加すると推定されている。医薬品市場の要因としては、医療需要の増加、技術の進歩、慢性疾患の有病率の上昇、医薬品製造分野の開発に対する民間&政府機関からの資金提供の増加、医薬品の研究開発活動の活発化などが挙げられる。しかし、厳しい規制、研究開発費の高騰、特許切れといった課題にも直面している。企業は、市場での競争力を維持し、必要とする患者に確実に製品を届けるために、継続的に技術革新を行い、こうした課題に適応していく必要がある。さらに、COVID-19の流行はワクチン開発とサプライチェーン・マネジメントの重要性を浮き彫りにし、製薬企業が新たな公衆衛生のニーズに機敏に対応する必要性をさらに強調している。

レポートの範囲
本レポートでは、抗生物質耐性の世界市場について、地域別・国別、タイプ別、用途別の分析とともに、総販売量、販売収益、価格、主要企業の市場シェア、ランキングを中心に包括的に紹介することを目的としています。
抗生物質耐性の市場規模、推計、予測は、2023年を基準年とし、2019年から2030年までの期間の履歴データと予測データを加えた販売量(K単位)と販売収益(百万ドル)で提供します。定量分析および定性分析により、読者が事業/成長戦略を策定し、市場競争状況を評価し、現在の市場における自社のポジションを分析し、抗生物質耐性に関する情報に基づいたビジネス上の意思決定を行うことを支援します。

市場区分
企業別
アラガン
アンプリファイバイオサイエンス
バイオバーシスGmbH
マクロライド・ファーマシューティカルズ
メリンタ・セラピューティクス
メルク
ナブリバ・セラピューティクス
ネメシスバイオサイエンス
ファージ・テクノロジーズ S.A
テトラフェーズ・ファーマシューティカルズ
ザ・メディシンズ・カンパニー
TPfizer
ウェストウェイ・ヘルス
タイプ別セグメント
疾患別
病原体別
用途別
オキサゾリジノン
リポグリコペプチド
テトラサイクリン
セファロスポリン
併用療法
その他
地域別
北米
米国
カナダ
欧州
ドイツ
フランス
英国
イタリア
ロシア
アジア太平洋
中国
日本
韓国
中国 台湾
東南アジア
インド
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦

各章の概要
第1章: レポートのスコープ、世界の総市場規模(バルブ、数量、価格)を紹介します。また本章では、市場ダイナミクス、市場の最新動向、市場の促進要因と制限要因、業界メーカーが直面する課題とリスク、業界の関連政策の分析を提供します。
第2章 抗生物質耐性メーカーの競争環境、価格、売上高、市場シェア、最新の開発計画、合併・買収情報などを詳細に分析します。
第3章:様々な市場セグメントをタイプ別に分析し、各市場セグメントの市場規模と発展可能性を網羅し、読者が様々な市場セグメントにおけるブルーオーシャン市場を見つけやすくします。
第4章:用途別の様々な市場セグメントの分析を提供し、各市場セグメントの市場規模と発展可能性をカバーし、読者が異なる下流市場でブルーオーシャン市場を見つけるのを助ける。
第5章:地域レベルでの抗生物質耐性の売上高、収益。各地域の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、将来の発展展望、市場空間、市場規模を紹介しています。
第6章 抗生物質耐性の国別売上高、収益。各国・地域のタイプ別、用途別のシグメイトデータを提供。
第7章:主要企業のプロファイルを提供し、製品の売上高、収益、価格、粗利益率、製品紹介、最近の開発など、市場の主要企業の基本的な状況を詳細に紹介します。
第8章:産業の上流と下流を含む産業チェーンの分析。
第9章:結論


ページTOPに戻る


目次

1 Market Overview
1.1 Antibiotic Resistance Product Introduction
1.2 Global Antibiotic Resistance Market Size Forecast
1.2.1 Global Antibiotic Resistance Sales Value (2019-2030)
1.2.2 Global Antibiotic Resistance Sales Volume (2019-2030)
1.2.3 Global Antibiotic Resistance Sales Price (2019-2030)
1.3 Antibiotic Resistance Market Trends & Drivers
1.3.1 Antibiotic Resistance Industry Trends
1.3.2 Antibiotic Resistance Market Drivers & Opportunity
1.3.3 Antibiotic Resistance Market Challenges
1.3.4 Antibiotic Resistance Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Antibiotic Resistance Players Revenue Ranking (2023)
2.2 Global Antibiotic Resistance Revenue by Company (2019-2024)
2.3 Global Antibiotic Resistance Players Sales Volume Ranking (2023)
2.4 Global Antibiotic Resistance Sales Volume by Company Players (2019-2024)
2.5 Global Antibiotic Resistance Average Price by Company (2019-2024)
2.6 Key Manufacturers Antibiotic Resistance Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Antibiotic Resistance Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Antibiotic Resistance
2.9 Antibiotic Resistance Market Competitive Analysis
2.9.1 Antibiotic Resistance Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Antibiotic Resistance Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibiotic Resistance as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 By Disease
3.1.2 By Pathogen
3.2 Global Antibiotic Resistance Sales Value by Type
3.2.1 Global Antibiotic Resistance Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Antibiotic Resistance Sales Value, by Type (2019-2030)
3.2.3 Global Antibiotic Resistance Sales Value, by Type (%) (2019-2030)
3.3 Global Antibiotic Resistance Sales Volume by Type
3.3.1 Global Antibiotic Resistance Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Antibiotic Resistance Sales Volume, by Type (2019-2030)
3.3.3 Global Antibiotic Resistance Sales Volume, by Type (%) (2019-2030)
3.4 Global Antibiotic Resistance Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Oxazolidinones
4.1.2 Lipoglycopeptides
4.1.3 Tetracyclines
4.1.4 Cephalosporins
4.1.5 Combination therapies
4.1.6 Other
4.2 Global Antibiotic Resistance Sales Value by Application
4.2.1 Global Antibiotic Resistance Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Antibiotic Resistance Sales Value, by Application (2019-2030)
4.2.3 Global Antibiotic Resistance Sales Value, by Application (%) (2019-2030)
4.3 Global Antibiotic Resistance Sales Volume by Application
4.3.1 Global Antibiotic Resistance Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Antibiotic Resistance Sales Volume, by Application (2019-2030)
4.3.3 Global Antibiotic Resistance Sales Volume, by Application (%) (2019-2030)
4.4 Global Antibiotic Resistance Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Antibiotic Resistance Sales Value by Region
5.1.1 Global Antibiotic Resistance Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Antibiotic Resistance Sales Value by Region (2019-2024)
5.1.3 Global Antibiotic Resistance Sales Value by Region (2025-2030)
5.1.4 Global Antibiotic Resistance Sales Value by Region (%), (2019-2030)
5.2 Global Antibiotic Resistance Sales Volume by Region
5.2.1 Global Antibiotic Resistance Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Antibiotic Resistance Sales Volume by Region (2019-2024)
5.2.3 Global Antibiotic Resistance Sales Volume by Region (2025-2030)
5.2.4 Global Antibiotic Resistance Sales Volume by Region (%), (2019-2030)
5.3 Global Antibiotic Resistance Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Antibiotic Resistance Sales Value, 2019-2030
5.4.2 North America Antibiotic Resistance Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Antibiotic Resistance Sales Value, 2019-2030
5.5.2 Europe Antibiotic Resistance Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Antibiotic Resistance Sales Value, 2019-2030
5.6.2 Asia Pacific Antibiotic Resistance Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Antibiotic Resistance Sales Value, 2019-2030
5.7.2 South America Antibiotic Resistance Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Antibiotic Resistance Sales Value, 2019-2030
5.8.2 Middle East & Africa Antibiotic Resistance Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Antibiotic Resistance Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Antibiotic Resistance Sales Value
6.2.1 Key Countries/Regions Antibiotic Resistance Sales Value, 2019-2030
6.2.2 Key Countries/Regions Antibiotic Resistance Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Antibiotic Resistance Sales Value, 2019-2030
6.3.2 United States Antibiotic Resistance Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Antibiotic Resistance Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Antibiotic Resistance Sales Value, 2019-2030
6.4.2 Europe Antibiotic Resistance Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Antibiotic Resistance Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Antibiotic Resistance Sales Value, 2019-2030
6.5.2 China Antibiotic Resistance Sales Value by Type (%), 2023 VS 2030
6.5.3 China Antibiotic Resistance Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Antibiotic Resistance Sales Value, 2019-2030
6.6.2 Japan Antibiotic Resistance Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Antibiotic Resistance Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Antibiotic Resistance Sales Value, 2019-2030
6.7.2 South Korea Antibiotic Resistance Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Antibiotic Resistance Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Antibiotic Resistance Sales Value, 2019-2030
6.8.2 Southeast Asia Antibiotic Resistance Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Antibiotic Resistance Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Antibiotic Resistance Sales Value, 2019-2030
6.9.2 India Antibiotic Resistance Sales Value by Type (%), 2023 VS 2030
6.9.3 India Antibiotic Resistance Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Allergan
7.1.1 Allergan Company Information
7.1.2 Allergan Introduction and Business Overview
7.1.3 Allergan Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Allergan Antibiotic Resistance Product Offerings
7.1.5 Allergan Recent Development
7.2 AmpliPhi Biosciences
7.2.1 AmpliPhi Biosciences Company Information
7.2.2 AmpliPhi Biosciences Introduction and Business Overview
7.2.3 AmpliPhi Biosciences Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)
7.2.4 AmpliPhi Biosciences Antibiotic Resistance Product Offerings
7.2.5 AmpliPhi Biosciences Recent Development
7.3 BioVersys GmbH
7.3.1 BioVersys GmbH Company Information
7.3.2 BioVersys GmbH Introduction and Business Overview
7.3.3 BioVersys GmbH Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)
7.3.4 BioVersys GmbH Antibiotic Resistance Product Offerings
7.3.5 BioVersys GmbH Recent Development
7.4 Macrolide Pharmaceuticals
7.4.1 Macrolide Pharmaceuticals Company Information
7.4.2 Macrolide Pharmaceuticals Introduction and Business Overview
7.4.3 Macrolide Pharmaceuticals Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Macrolide Pharmaceuticals Antibiotic Resistance Product Offerings
7.4.5 Macrolide Pharmaceuticals Recent Development
7.5 Melinta Therapeutics
7.5.1 Melinta Therapeutics Company Information
7.5.2 Melinta Therapeutics Introduction and Business Overview
7.5.3 Melinta Therapeutics Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Melinta Therapeutics Antibiotic Resistance Product Offerings
7.5.5 Melinta Therapeutics Recent Development
7.6 Merck
7.6.1 Merck Company Information
7.6.2 Merck Introduction and Business Overview
7.6.3 Merck Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Merck Antibiotic Resistance Product Offerings
7.6.5 Merck Recent Development
7.7 Nabriva Therapeutics
7.7.1 Nabriva Therapeutics Company Information
7.7.2 Nabriva Therapeutics Introduction and Business Overview
7.7.3 Nabriva Therapeutics Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Nabriva Therapeutics Antibiotic Resistance Product Offerings
7.7.5 Nabriva Therapeutics Recent Development
7.8 Nemesis Bioscience
7.8.1 Nemesis Bioscience Company Information
7.8.2 Nemesis Bioscience Introduction and Business Overview
7.8.3 Nemesis Bioscience Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Nemesis Bioscience Antibiotic Resistance Product Offerings
7.8.5 Nemesis Bioscience Recent Development
7.9 Phage Technologies S.A
7.9.1 Phage Technologies S.A Company Information
7.9.2 Phage Technologies S.A Introduction and Business Overview
7.9.3 Phage Technologies S.A Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Phage Technologies S.A Antibiotic Resistance Product Offerings
7.9.5 Phage Technologies S.A Recent Development
7.10 Tetraphase Pharmaceuticals
7.10.1 Tetraphase Pharmaceuticals Company Information
7.10.2 Tetraphase Pharmaceuticals Introduction and Business Overview
7.10.3 Tetraphase Pharmaceuticals Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Tetraphase Pharmaceuticals Antibiotic Resistance Product Offerings
7.10.5 Tetraphase Pharmaceuticals Recent Development
7.11 The Medicines Company
7.11.1 The Medicines Company Company Information
7.11.2 The Medicines Company Introduction and Business Overview
7.11.3 The Medicines Company Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)
7.11.4 The Medicines Company Antibiotic Resistance Product Offerings
7.11.5 The Medicines Company Recent Development
7.12 TPfizer
7.12.1 TPfizer Company Information
7.12.2 TPfizer Introduction and Business Overview
7.12.3 TPfizer Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)
7.12.4 TPfizer Antibiotic Resistance Product Offerings
7.12.5 TPfizer Recent Development
7.13 Westway Health
7.13.1 Westway Health Company Information
7.13.2 Westway Health Introduction and Business Overview
7.13.3 Westway Health Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Westway Health Antibiotic Resistance Product Offerings
7.13.5 Westway Health Recent Development
8 Industry Chain Analysis
8.1 Antibiotic Resistance Industrial Chain
8.2 Antibiotic Resistance Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Antibiotic Resistance Sales Model
8.5.2 Sales Channel
8.5.3 Antibiotic Resistance Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

 

ページTOPに戻る


 

Summary

Antibiotic are medicines that are used to prevent various bacterial infections and antibiotic resistance is the inability of a microorganism to withstand the effects of an antibiotic. It is a specific type of drug resistance. These bacteria may infect humans and animals body, and the infections they cause are harder to treat than those caused by non-resistant bacteria. Hence, antibiotic resistance leads to higher medical costs and increased mortality.
The global market for Antibiotic Resistance was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Antibiotic Resistance, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Antibiotic Resistance by region & country, by Type, and by Application.
The Antibiotic Resistance market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibiotic Resistance.

Market Segmentation
By Company
Allergan
AmpliPhi Biosciences
BioVersys GmbH
Macrolide Pharmaceuticals
Melinta Therapeutics
Merck
Nabriva Therapeutics
Nemesis Bioscience
Phage Technologies S.A
Tetraphase Pharmaceuticals
The Medicines Company
TPfizer
Westway Health
Segment by Type:
By Disease
By Pathogen
Segment by Application
Oxazolidinones
Lipoglycopeptides
Tetracyclines
Cephalosporins
Combination therapies
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Antibiotic Resistance manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Antibiotic Resistance in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Antibiotic Resistance in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.



ページTOPに戻る


Table of Contents

1 Market Overview
1.1 Antibiotic Resistance Product Introduction
1.2 Global Antibiotic Resistance Market Size Forecast
1.2.1 Global Antibiotic Resistance Sales Value (2019-2030)
1.2.2 Global Antibiotic Resistance Sales Volume (2019-2030)
1.2.3 Global Antibiotic Resistance Sales Price (2019-2030)
1.3 Antibiotic Resistance Market Trends & Drivers
1.3.1 Antibiotic Resistance Industry Trends
1.3.2 Antibiotic Resistance Market Drivers & Opportunity
1.3.3 Antibiotic Resistance Market Challenges
1.3.4 Antibiotic Resistance Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Antibiotic Resistance Players Revenue Ranking (2023)
2.2 Global Antibiotic Resistance Revenue by Company (2019-2024)
2.3 Global Antibiotic Resistance Players Sales Volume Ranking (2023)
2.4 Global Antibiotic Resistance Sales Volume by Company Players (2019-2024)
2.5 Global Antibiotic Resistance Average Price by Company (2019-2024)
2.6 Key Manufacturers Antibiotic Resistance Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Antibiotic Resistance Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Antibiotic Resistance
2.9 Antibiotic Resistance Market Competitive Analysis
2.9.1 Antibiotic Resistance Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Antibiotic Resistance Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibiotic Resistance as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 By Disease
3.1.2 By Pathogen
3.2 Global Antibiotic Resistance Sales Value by Type
3.2.1 Global Antibiotic Resistance Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Antibiotic Resistance Sales Value, by Type (2019-2030)
3.2.3 Global Antibiotic Resistance Sales Value, by Type (%) (2019-2030)
3.3 Global Antibiotic Resistance Sales Volume by Type
3.3.1 Global Antibiotic Resistance Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Antibiotic Resistance Sales Volume, by Type (2019-2030)
3.3.3 Global Antibiotic Resistance Sales Volume, by Type (%) (2019-2030)
3.4 Global Antibiotic Resistance Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Oxazolidinones
4.1.2 Lipoglycopeptides
4.1.3 Tetracyclines
4.1.4 Cephalosporins
4.1.5 Combination therapies
4.1.6 Other
4.2 Global Antibiotic Resistance Sales Value by Application
4.2.1 Global Antibiotic Resistance Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Antibiotic Resistance Sales Value, by Application (2019-2030)
4.2.3 Global Antibiotic Resistance Sales Value, by Application (%) (2019-2030)
4.3 Global Antibiotic Resistance Sales Volume by Application
4.3.1 Global Antibiotic Resistance Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Antibiotic Resistance Sales Volume, by Application (2019-2030)
4.3.3 Global Antibiotic Resistance Sales Volume, by Application (%) (2019-2030)
4.4 Global Antibiotic Resistance Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Antibiotic Resistance Sales Value by Region
5.1.1 Global Antibiotic Resistance Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Antibiotic Resistance Sales Value by Region (2019-2024)
5.1.3 Global Antibiotic Resistance Sales Value by Region (2025-2030)
5.1.4 Global Antibiotic Resistance Sales Value by Region (%), (2019-2030)
5.2 Global Antibiotic Resistance Sales Volume by Region
5.2.1 Global Antibiotic Resistance Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Antibiotic Resistance Sales Volume by Region (2019-2024)
5.2.3 Global Antibiotic Resistance Sales Volume by Region (2025-2030)
5.2.4 Global Antibiotic Resistance Sales Volume by Region (%), (2019-2030)
5.3 Global Antibiotic Resistance Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Antibiotic Resistance Sales Value, 2019-2030
5.4.2 North America Antibiotic Resistance Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Antibiotic Resistance Sales Value, 2019-2030
5.5.2 Europe Antibiotic Resistance Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Antibiotic Resistance Sales Value, 2019-2030
5.6.2 Asia Pacific Antibiotic Resistance Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Antibiotic Resistance Sales Value, 2019-2030
5.7.2 South America Antibiotic Resistance Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Antibiotic Resistance Sales Value, 2019-2030
5.8.2 Middle East & Africa Antibiotic Resistance Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Antibiotic Resistance Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Antibiotic Resistance Sales Value
6.2.1 Key Countries/Regions Antibiotic Resistance Sales Value, 2019-2030
6.2.2 Key Countries/Regions Antibiotic Resistance Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Antibiotic Resistance Sales Value, 2019-2030
6.3.2 United States Antibiotic Resistance Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Antibiotic Resistance Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Antibiotic Resistance Sales Value, 2019-2030
6.4.2 Europe Antibiotic Resistance Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Antibiotic Resistance Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Antibiotic Resistance Sales Value, 2019-2030
6.5.2 China Antibiotic Resistance Sales Value by Type (%), 2023 VS 2030
6.5.3 China Antibiotic Resistance Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Antibiotic Resistance Sales Value, 2019-2030
6.6.2 Japan Antibiotic Resistance Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Antibiotic Resistance Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Antibiotic Resistance Sales Value, 2019-2030
6.7.2 South Korea Antibiotic Resistance Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Antibiotic Resistance Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Antibiotic Resistance Sales Value, 2019-2030
6.8.2 Southeast Asia Antibiotic Resistance Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Antibiotic Resistance Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Antibiotic Resistance Sales Value, 2019-2030
6.9.2 India Antibiotic Resistance Sales Value by Type (%), 2023 VS 2030
6.9.3 India Antibiotic Resistance Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Allergan
7.1.1 Allergan Company Information
7.1.2 Allergan Introduction and Business Overview
7.1.3 Allergan Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Allergan Antibiotic Resistance Product Offerings
7.1.5 Allergan Recent Development
7.2 AmpliPhi Biosciences
7.2.1 AmpliPhi Biosciences Company Information
7.2.2 AmpliPhi Biosciences Introduction and Business Overview
7.2.3 AmpliPhi Biosciences Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)
7.2.4 AmpliPhi Biosciences Antibiotic Resistance Product Offerings
7.2.5 AmpliPhi Biosciences Recent Development
7.3 BioVersys GmbH
7.3.1 BioVersys GmbH Company Information
7.3.2 BioVersys GmbH Introduction and Business Overview
7.3.3 BioVersys GmbH Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)
7.3.4 BioVersys GmbH Antibiotic Resistance Product Offerings
7.3.5 BioVersys GmbH Recent Development
7.4 Macrolide Pharmaceuticals
7.4.1 Macrolide Pharmaceuticals Company Information
7.4.2 Macrolide Pharmaceuticals Introduction and Business Overview
7.4.3 Macrolide Pharmaceuticals Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Macrolide Pharmaceuticals Antibiotic Resistance Product Offerings
7.4.5 Macrolide Pharmaceuticals Recent Development
7.5 Melinta Therapeutics
7.5.1 Melinta Therapeutics Company Information
7.5.2 Melinta Therapeutics Introduction and Business Overview
7.5.3 Melinta Therapeutics Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Melinta Therapeutics Antibiotic Resistance Product Offerings
7.5.5 Melinta Therapeutics Recent Development
7.6 Merck
7.6.1 Merck Company Information
7.6.2 Merck Introduction and Business Overview
7.6.3 Merck Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Merck Antibiotic Resistance Product Offerings
7.6.5 Merck Recent Development
7.7 Nabriva Therapeutics
7.7.1 Nabriva Therapeutics Company Information
7.7.2 Nabriva Therapeutics Introduction and Business Overview
7.7.3 Nabriva Therapeutics Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Nabriva Therapeutics Antibiotic Resistance Product Offerings
7.7.5 Nabriva Therapeutics Recent Development
7.8 Nemesis Bioscience
7.8.1 Nemesis Bioscience Company Information
7.8.2 Nemesis Bioscience Introduction and Business Overview
7.8.3 Nemesis Bioscience Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Nemesis Bioscience Antibiotic Resistance Product Offerings
7.8.5 Nemesis Bioscience Recent Development
7.9 Phage Technologies S.A
7.9.1 Phage Technologies S.A Company Information
7.9.2 Phage Technologies S.A Introduction and Business Overview
7.9.3 Phage Technologies S.A Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Phage Technologies S.A Antibiotic Resistance Product Offerings
7.9.5 Phage Technologies S.A Recent Development
7.10 Tetraphase Pharmaceuticals
7.10.1 Tetraphase Pharmaceuticals Company Information
7.10.2 Tetraphase Pharmaceuticals Introduction and Business Overview
7.10.3 Tetraphase Pharmaceuticals Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Tetraphase Pharmaceuticals Antibiotic Resistance Product Offerings
7.10.5 Tetraphase Pharmaceuticals Recent Development
7.11 The Medicines Company
7.11.1 The Medicines Company Company Information
7.11.2 The Medicines Company Introduction and Business Overview
7.11.3 The Medicines Company Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)
7.11.4 The Medicines Company Antibiotic Resistance Product Offerings
7.11.5 The Medicines Company Recent Development
7.12 TPfizer
7.12.1 TPfizer Company Information
7.12.2 TPfizer Introduction and Business Overview
7.12.3 TPfizer Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)
7.12.4 TPfizer Antibiotic Resistance Product Offerings
7.12.5 TPfizer Recent Development
7.13 Westway Health
7.13.1 Westway Health Company Information
7.13.2 Westway Health Introduction and Business Overview
7.13.3 Westway Health Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Westway Health Antibiotic Resistance Product Offerings
7.13.5 Westway Health Recent Development
8 Industry Chain Analysis
8.1 Antibiotic Resistance Industrial Chain
8.2 Antibiotic Resistance Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Antibiotic Resistance Sales Model
8.5.2 Sales Channel
8.5.3 Antibiotic Resistance Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同じKEY WORD()の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/23 10:26

157.72 円

164.94 円

201.11 円

ページTOPに戻る